Cytatx
<UNKNOWN> · 1 known investors
Cyta Therapeutics develops polymer-based nanogel therapeutics (IntelliGels) to treat obesity, NASH, type 2 diabetes, and metabolic disorders. The company's lead program, Cyta-001, is a liver-targeted drug delivery system encapsulating a thyroid hormone receptor agonist for metabolic disease management.
BiotechHealthtechMedical Devices
Founders & leadership
BC
Bernadette C. FendrockChief Executive Officer, founder
WS
W. Stephen FaraciChief Scientific Officer, founder
ST
S. ThayumanavanCo-founder